BSEJK Agri Genetics LtdHighNeutral
Announced Fri, 16 May · 20:06 IST

Outcome of the Board Meeting

Emphasis Of MatterRevenue DeclinePat NegativeExceptional ItemResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board approved audited financial results (standalone and consolidated) for Q4 and FY ended 31st March 2025, with the auditors (Lodha & Co LLP) issuing an unmodified opinion. No dividend was recommended for FY25. Standalone revenue from operations rose modestly to ₹16,178.73 lakhs (FY24: ₹14,810.03 lakhs), but the company still posted a net loss of ₹250.44 lakhs, significantly narrower than the ₹2,082.08 lakh loss in FY24. The improvement was largely driven by an exceptional gain of ₹1,248.50 lakhs from the sale of agricultural land. Q4 standalone revenue declined sharply to ₹2,758.70 lakhs from ₹3,574.99 lakhs a year ago, though the quarterly loss narrowed. The auditor flagged an emphasis of matter regarding overdue trade receivables of ₹1,823.61 lakhs and a ₹121.68 lakh security deposit from Rajasthan State Seeds Corporation, where arbitration went against the company on limitation grounds and a Section 34 application is pending. The Board also appointed M/s Ronak Jhuthawat & Co as Secretarial Auditors for five years (FY26–FY30), subject to shareholder approval.

Likely market impact

The loss narrowed year-on-year, but profitability is propped up by a one-time land sale gain rather than core operations, and Q4 revenue fell sharply. The unresolved RSSC receivable is a notable overhang. No dividend means no cash return for shareholders, and near-term stock sentiment may remain weak given the operating losses.